Foster Dykema Cabot & Co’s Bruker BRKR Stock Holding History

Foster Dykema Cabot & Co’s Portfolio BRKR Stock Details BRKR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-82	Closed	-$6K	–	336
2023 Q2	$6K	Buy	+82	New	+$6.25K	﹤0.01%	287

Other funds holding BRKR

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PCA

Pallas Capital Advisors Braintree, Massachusetts $2.66B AUM 22.31% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Foster Dykema Cabot & Co's BRKR Position: Q3 2023 in Review

Foster Dykema Cabot & Co sold out of Bruker (BRKR) in Q3 2023, closing a stake of 82 shares — an estimated $6K sold.

Foster Dykema Cabot & Co first reported a position in BRKR in Q2 2023 and held it in 1 quarter. The position peaked at $6K in Q2 2023. 345 funds tracked by Wall St. Rank hold BRKR as of Q3 2023.

Foster Dykema Cabot & Co reported no remaining Bruker position as of Q3 2023 after selling out during the quarter.
Foster Dykema Cabot & Co sold 82 Bruker shares in Q3 2023, an estimated $6K.
Foster Dykema Cabot & Co first reported a position in Bruker in Q2 2023 and held it in 1 quarter.
Foster Dykema Cabot & Co's Bruker position peaked at $6K in Q2 2023.
345 funds tracked by Wall St. Rank held Bruker as of Q3 2023.

Based on Foster Dykema Cabot & Co's 13F filing for Q3 2023, filed 14 Nov 2023.